162 related articles for article (PubMed ID: 12375715)
21. Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug.
Suwaki T; Agrawal DK; Townley RG
Int Immunopharmacol; 2001 Nov; 1(12):2163-71. PubMed ID: 11710545
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
23. [Successful treatment of chronic eosinophilic pneumonia with suplatast tosilate].
Kusumoto H; Mizuno K; Yonemaru M; Nakano M; Ichinose Y; Toyama K
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 May; 35(5):550-4. PubMed ID: 9234634
[TBL] [Abstract][Full Text] [Related]
24. Omalizumab is more effective than suplatast tosilate in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis.
Nagakura T; Ogino S; Okubo K; Sato N; Takahashi M; Ishikawa T
Clin Exp Allergy; 2008 Feb; 38(2):329-37. PubMed ID: 18070163
[TBL] [Abstract][Full Text] [Related]
25. [Chronic eosinophilic pneumonia successfully treated with suplatast tosilate].
Hamada H; Sakatani M; Nishioka M; Akira M; Yamamoto S; Ueda E; Okano Y; Nakamura Y; Sone S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):692-7. PubMed ID: 9294307
[TBL] [Abstract][Full Text] [Related]
26. [Cytokine production by peripheral blood mononuclear cells in bronchial asthma treated with suplatast tosilate].
Yamasawa H; Oshikawa K; Sugiyama Y
Arerugi; 2001 Jun; 50(6):513-9. PubMed ID: 11517513
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of pediatric hypereosinophilic syndrome with suplatast tosilate.
Yamada Y; Yoshihara S; Arisaka O
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):380-1. PubMed ID: 17941289
[No Abstract] [Full Text] [Related]
28. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
[TBL] [Abstract][Full Text] [Related]
29. The effects of suplatast tosilate treatment and prophylaxis on lung histopathology in a mouse model of chronic asthma.
Tuncel T; Karaman M; Ayyildiz ZA; Uysal P; Kiray M; Bagriyanik AH; Yilmaz O; Karaman O; Uzuner N
J Investig Med; 2014 Jan; 62(1):56-61. PubMed ID: 24113733
[TBL] [Abstract][Full Text] [Related]
30. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
Kimata H
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221
[TBL] [Abstract][Full Text] [Related]
31. [Cough-variant asthma successfully treated with suplatast tosilate].
Fujimori K; Suzuki E; Arakawa M
Arerugi; 1998 Jul; 47(7):694-7. PubMed ID: 9780445
[No Abstract] [Full Text] [Related]
32. [Anti-inflammatory drugs for the treatment of bronchial hyperresponsiveness].
Sano Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():48-53. PubMed ID: 9216184
[TBL] [Abstract][Full Text] [Related]
33. Improvement of alanine aminotransferase by administration of suplatast tosilate plus ursodeoxycholic acid in patients with resistance to ursodeoxycholic acid monotherapy on hepatitis C virus-related chronic liver disease.
Matsuda Y; Inada M; Maeda H; Matsuyama T
Intern Med; 2002 Oct; 41(10):774-9. PubMed ID: 12412994
[TBL] [Abstract][Full Text] [Related]
34. [A case report of eosinophilic cystitis treated with oral suplatast tosilate].
Kuramoto T; Senzaki H; Inagaki T
Hinyokika Kiyo; 2014 Sep; 60(9):447-50. PubMed ID: 25293800
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of eosinophilic gastroenteritis with suplatast tosilate.
Shirai T; Hashimoto D; Suzuki K; Osawa S; Aonahata M; Chida K; Nakamura H
J Allergy Clin Immunol; 2001 May; 107(5):924-5. PubMed ID: 11344364
[No Abstract] [Full Text] [Related]
36. Suplatast tosilate, a new type of antiallergic agent, prevents the expression of airway hyperresponsiveness in guinea pigs.
Taniguchi H; Togawa M; Ohwada K; Kiniwa M; Matsuura N; Nagai H; Koda A
Eur J Pharmacol; 1996 Dec; 318(2-3):447-54. PubMed ID: 9016937
[TBL] [Abstract][Full Text] [Related]
37. Suplatast tosilate inhibits thymus- and activation-regulated chemokine production by antigen-specific human Th2 cells.
Oda N; Minoguchi K; Tanaka A; Yokoe T; Minoguchi H; Matsuo H; Nakashima M; Tasaki T; Adachi M
Clin Exp Allergy; 2002 Dec; 32(12):1782-6. PubMed ID: 12653172
[TBL] [Abstract][Full Text] [Related]
38. [Chronic eosinophilic pneumonia complicated by bronchial asthma and diabetes mellitus successfully treated with suplatast tosilate and high-dose inhaled corticosteroid therapy].
Fujimori K; Shimatsu Y; Suzuki E; Arakawa M; Gejyo F
Nihon Kokyuki Gakkai Zasshi; 1999 Nov; 37(11):903-8. PubMed ID: 18217313
[TBL] [Abstract][Full Text] [Related]
39. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice.
Furonaka M; Hattori N; Tanimoto T; Senoo T; Ishikawa N; Fujitaka K; Haruta Y; Yokoyama A; Kohno N
J Pharmacol Exp Ther; 2009 Jan; 328(1):55-61. PubMed ID: 18832650
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic effectiveness of suplatast tosilate in children with asthma symptoms in the autumn: a pilot study.
Yoshihara S; Yamada Y; Fukuda H; Tsuchiya T; Ono M; Fukuda N; Kanno N; Arisaka O
Allergol Int; 2014 Jun; 63(2):199-203. PubMed ID: 24561769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
